Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

Biotechnology

Healthcare
$0.90 +3.01%

+$0.06 today

Market cap
$54.28M
Beta
1.19
P/E (TTM)
-4.2
EPS (TTM)
-$0.45
52W Low $1.07High $6.18

Volume 1.45M

Average 2.13M

Balance Sheet

Inspect the capital base behind the business.

Assets

$72.06M

FY 2025 · Annual

-31.1% YoY

Liabilities

$27.81M

FY 2025 · Annual

-17.2% YoY

Equity

$44.25M

FY 2025 · Annual

-37.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents229.79M144.42M142.82M54.53M70.04M
Short-term Investments029.88M046.62M0
Net Receivables28.77K3.24M000
Inventory00000
Other Current Assets2.5M3.05M4.65M2.51M1.34M
Total Current Assets232.75M181.02M147.81M104.07M71.78M
Property, Plant & Equipment (Net)384.35K268.54K516.58K266.96K275.86K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets000267.26K0
Total Non-current Assets384.35K268.54K516.58K534.22K275.86K
Total Assets233.14M181.29M148.33M104.61M72.06M
Account Payables1.02M133.63K1.34M180.45K158.46K
Short-term Debt229.61K911.76K15.15M31.37K15.25M
Tax Payables00000
Deferred Revenue0006M6M
Other Current Liabilities1.51M3.82M3.09M4.33M4.27M
Total Current Liabilities11.77M15.36M22.26M18.6M27.81M
Long-term Debt15.5M14.92M015M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)006M00
Other Non-current Liabilities00000
Total Non-current Liabilities15.63M14.92M6.27M15M0
Total Liabilities27.4M30.28M28.53M33.6M27.81M
Common Stock58.08K58.56K59.2K59.65K60.16K
Retained Earnings(294.69M)(356.72M)(394.26M)(450.11M)(483.96M)
Accumulated OCI0(103.94K)037.44K0
Other Stockholders Equity00000
Minority Interest00000
Total Equity205.74M151.01M119.8M71M44.25M
Total Debt15.86M16.08M15.66M15.3M15.53M
Net Debt(213.93M)(128.34M)(127.17M)(39.22M)(54.51M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$65.0M
Other Current$1.3M
Total Current Assets$66.3M
PP&E (Net)$209.3K
Total Non-current Assets$209.3K
Total Assets$66.5M

Analysis

Selected assets total $66.5M for Latest. The largest visible component is Cash & Equivalents at $65.0M, about 97.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingAug 12, 2026
10-QQuarterly reportAug 6, 2026
8-KCurrent reportJul 30, 2026
SC 13G/ASC 13G/A filingJul 27, 2026
8-KCurrent reportJul 15, 2026

How much cash does ALDX have?

Aldeyra Therapeutics, Inc. (ALDX) reported $70.04M in cash and equivalents in fiscal 2025.

How much debt does ALDX carry?

Aldeyra Therapeutics, Inc. (ALDX) reported $15.53M of total debt, with net debt of -$54.51M.